OIS at AAO 2015

GrayBug

Nov 12, 2015 9:02am ‐ Nov 12, 2015 9:10am


Description

GrayBug is developing injectable controlled release technologies to reduce the frequency of ocular therapy to a few times per year (2-3 per year). These technologies have solved the problems with tolerability and blockage of vision noted with many injectable sustained release ocular products for wet AMD and glaucoma.

Speaker(s):

You must be logged in and own this session in order to post comments.